Literature DB >> 7030373

The combination of nifedipine and propranolol in the management of patients with angina pectoris.

A C Tweddel, J M Beattie, R G Murray, I Hutton.   

Abstract

1 A double-blind cross over study was carried out to assess the effects of the combination of nifedipine and propranolol in 25 patients with chronic stable angina pectoris at beta-adrenoceptor blockade. 2 Efficacy was judged objectively by a standardized exercise protocol using a bicycle ergometer and subjectively by patient assessment of anginal attack rate. 3 The combination of nifedipine and propranolol was shown to be effective with an increase in exercise time to angina and an increase in physical work capacity expressed in terms of calculated maximal oxygen uptake (VO2 max). There was an associated reduction in anginal attack rate. 4 The synergistic effect was even more pronounced after reduction in propranolol dosage to 50% of the beta-adrenoceptor blocking dose, reflecting the myocardial depressant effects of beta-adrenoceptor blocking drugs in these patients with coronary heart disease, some of whom had poor left ventricular function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030373      PMCID: PMC1401877          DOI: 10.1111/j.1365-2125.1981.tb01205.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

Review 1.  Exercise testing in rheumatic heart disease.

Authors:  C G Blomqvist
Journal:  Cardiovasc Clin       Date:  1973

Review 2.  Control of myocardial oxygen consumption: physiologic and clinical considerations.

Authors:  E Braunwald
Journal:  Am J Cardiol       Date:  1971-04       Impact factor: 2.778

3.  Maximal oxygen uptake.

Authors:  J H Mitchell; G Blomqvist
Journal:  N Engl J Med       Date:  1971-05-06       Impact factor: 91.245

4.  Combined propranolol and digoxin therapy in angina pectoris.

Authors:  M H Crawford; M M LeWinter; R A O'Rourke; J S Karliner; J Ross
Journal:  Ann Intern Med       Date:  1975-10       Impact factor: 25.391

Review 5.  Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  Drugs       Date:  1974       Impact factor: 9.546

6.  Haemodynamic effects of nifedipine in heart failure.

Authors:  S Klugmann; A Salvi; F Camerini
Journal:  Br Heart J       Date:  1980-04

7.  Muscular subaortic stenosis. Reversibility with varying cardiac cycle length.

Authors:  E W Hancock; F Eldridge
Journal:  Am J Cardiol       Date:  1966-10       Impact factor: 2.778

8.  Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.

Authors:  D J Coltart; D G Shand
Journal:  Br Med J       Date:  1970-09-26

9.  Effect of nifedipine on exercise tolerance in patients with angina pectoris.

Authors:  J H Atterhög; L G Ekelund; A L Melin
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

10.  A method for praecordial surface mapping of the exercise electrocardiogram.

Authors:  K M Fox; A P Selwyn; J P Shillingford
Journal:  Br Heart J       Date:  1978-12
View more
  15 in total

Review 1.  The combination of slow-release nifedipine and atenolol for stable angina.

Authors:  D G Waller; V F Challenor
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 3.  Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.

Authors:  J N Lessem; B N Singh
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

Review 4.  Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris.

Authors:  V F Challenor; D G Waller; C F George
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

5.  Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function.

Authors:  I N Findlay; K MacLeod; M Ford; G Gillen; A T Elliott; H J Dargie
Journal:  Br Heart J       Date:  1986-03

6.  Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease.

Authors:  B Silke; S P Verma; G I Nelson; M Hussain; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

7.  Combination of metoprolol with molsidomine in the treatment of angina pectoris.

Authors:  J P van Mantgem; K I Lie; A W Matroos
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Are propranolol and nifedipine synergistic in angina pectoris?

Authors:  B C Campbell
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

9.  Slow release nifedipine plus atenolol in chronic stable angina pectoris.

Authors:  V F Challenor; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

10.  A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris.

Authors:  I N Findlay; K MacLeod; G Gillen; A T Elliott; T Aitchison; H J Dargie
Journal:  Br Heart J       Date:  1987-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.